Download | < Back |
12 May 2022 | |
Statement of deviation(s) or variation(s) under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019 for quarter ended March 31, 2022 | |
View all announcements for Windlas Biotech Ltd | Source: BSE India |